Search

everythinglearnresearchcommunity

for

Search:↓

5-Bromo-3,4-dihydroxybenzaldehyde could potentially help hair growth by activating certain cell pathways and inhibiting others.

A new Wnt surrogate specifically targets the Frizzled7 receptor, promoting organoid formation and hair growth.

The three estrogen receptor genes are highly expressed in zebrafish neuromasts during development.

Polyamines help repair DNA breaks and may influence cancer development.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Gene expression in milk cells and blood can help detect illegal rbST use in cows.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Plasma protein binding significantly affects glucocorticosteroid concentration in blood, saliva, and hair.

Hair growth drugs and epidermal growth factor do not change the calcium binding site gradient in hair follicles.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

The mutation causes hairless mice due to mislocalized and dysfunctional HR protein.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

New probes were created to effectively measure specific enzymes involved in fat metabolism, which could help develop new drugs.

A new gene mutation causes vitamin D resistance and rickets, treatable with calcium therapy.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

The study found potential new DNA patterns in fertility genes, but further testing is needed.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Certain gene variations may increase the risk and severity of alopecia areata.

DrugNet effectively identifies new uses for existing drugs and may save resources in drug development.

B cells can both help and hinder the body's defense against melanoma.

New mutations in the VDR gene cause vitamin D-resistant rickets without hair loss.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

DNMT1 may help treat hypospadias by improving cell function and preventing unwanted cell changes.

Method accurately measures finasteride in tablets using finasteride-BSA interaction.